References analysis of the Wikipedia article "Substancia P" in the Galician version

doi.org

dx.doi.org

Harrison S, Geppetti P (2001). "Substance p". The International Journal of Biochemistry & Cell Biology 33 (6): 555–76. PMID 11378438. doi:10.1016/S1357-2725(01)00031-0.

Datar P, Srivastava S, Coutinho E, Govil G (2004). "Substance P: structure, function, and therapeutics". Current Topics in Medicinal Chemistry 4 (1): 75–103. PMID 14754378. doi:10.2174/1568026043451636. Arquivado dende o orixinal o 17 de agosto de 2009. Consultado o 19 de setembro de 2018.

v. Euler, U. S.; Gaddum, J. H. (1931-06-06). "An unidentified depressor substance in certain tissue extracts". The Journal of Physiology (en inglés) 72 (1): 74–87. PMC 1403098. PMID 16994201. doi:10.1113/jphysiol.1931.sp002763.

Gerard NP, Garraway LA, Eddy RL Jr, Shows TB, Iijima H, Paquet JL, Gerard C (1991). "Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones". Biochemistry 30 (44): 10640–6. PMID 1657150. doi:10.1021/bi00108a006.

Maggi CA (1995). "The mammalian tachykinin receptors". Gen. Pharmacol. 26 (5): 911–44. PMID 7557266. doi:10.1016/0306-3623(94)00292-U.

Yip J, Chahl LA (2001). "Localization of NK1 and NK3 receptors in guinea-pig brain". Regulatory peptides 98 (1-2): 55–62. PMID 11179779. doi:10.1016/S0167-0115(00)00228-7.

Gobbi G, Cassano T, Radja F, Morgese MG, Cuomo V, Santarelli L, Hen R, Blier P (2007). "Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function". European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 17 (5): 328–38. PMID 16950604. doi:10.1016/j.euroneuro.2006.07.004.

Kovács KA, Steinmann M, Magistretti PJ, Halfon O, Cardinaux JR (2006). "C/EBPbeta couples dopamine signalling to substance P precursor gene expression in striatal neurones". Journal of Neurochemistry 98 (5): 1390–9. PMID 16771829. doi:10.1111/j.1471-4159.2006.03957.x.

Rameshwar P (1997). "Substance P: a regulatory neuropeptide for hematopoiesis and immune functions". Clinical Immunology and Immunopathology 85 (2): 129–33. PMID 9344694. doi:10.1006/clin.1997.4446.

De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, Laird JM, Belmonte C, Cervero F, Hunt SP (1998). "Altered nociception, analgesia and aggression in mice lacking the receptor for substance P". Nature 392 (6674): 394–7. PMID 9537323. doi:10.1038/32904.

Ebner K, Singewald N (2006). "The role of substance P in stress and anxiety responses". Amino Acids 31 (3): 251–72. PMID 16820980. doi:10.1007/s00726-006-0335-9.

Huston JP, Hasenöhrl RU, Boix F, Gerhardt P, Schwarting RK (1993). "Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity". Psychopharmacology 112 (2-3): 147–62. PMID 7532865. doi:10.1007/BF02244906.

Park SW, Yan YP, Satriotomo I, Vemuganti R, Dempsey RJ (2007). "Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions". Journal of neurosurgery 107 (3): 593–9. PMID 17886560. doi:10.3171/JNS-07/09/0593.

Bonham AC (1995). "Neurotransmitters in the CNS control of breathing". Respiration physiology 101 (3): 219–30. PMID 8606995. doi:10.1016/0034-5687(95)00045-F.

Hesketh PJ (2001). "Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting". Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 9 (5): 350–4. PMID 11497388. doi:10.1007/s005200000199.

Donkin JJ, Turner RJ, Hassan I, Vink R (2007). "Substance P in traumatic brain injury". Progress in brain research 161: 97–109. PMID 17618972. doi:10.1016/S0079-6123(06)61007-8.

Hornby PJ (2001). "Central neurocircuitry associated with emesis". The American Journal of Medicine. 111. Suppl 8A (8): 106S–112S. PMID 11749934. doi:10.1016/S0002-9343(01)00849-X.

Donkin JJ, Nimmo AJ, Cernak I, Blumbergs PC, Vink R (2009). "Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury". J Cereb Blood Flow Metab. 29 (8): 1388–98. PMID 19436311. doi:10.1038/jcbfm.2009.63.

Reid TW, Murphy CJ, Iwahashi CK, Foster BA, Mannis MJ (1993). "Stimulation of epithelial cell growth by the neuropeptide substance P". Journal of Cellular Biochemistry 52 (4): 476–85. PMID 7693729. doi:10.1002/jcb.240520411.

Tsui H, Razavi R, Chan Y, Yantha J, Dosch HM (2007). "'Sensing' autoimmunity in type 1 diabetes". Trends in Molecular Medicine 13 (10): 405–13. PMID 17900987. doi:10.1016/j.molmed.2007.07.006.

Brown, M and Vale, W (1976). "Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels". Endocrinology 98 (3): 819–822. PMID 1261503. doi:10.1210/endo-98-3-819.

Wong BJ, Tublitz NJ, Minson CT (2005). "Neurokinin-1 receptor desensitization to consecutive microdialysis infusions of substance P in human skin". The Journal of Physiology 568 (Pt 3): 1047–56. PMC 1464169. PMID 16123103. doi:10.1113/jphysiol.2005.095372.

Hon KL, Lam MC, Wong KY, Leung TF, Ng PC (2007). "Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P". The British Journal of Dermatology 157 (5): 922–5. PMID 17725670. doi:10.1111/j.1365-2133.2007.08149.x.

Stark D, van Hal S, Marriott D, Ellis J, Harkness J (2007). "Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis". Int. J. Parasitol. 37 (1): 11–20. PMID 17070814. doi:10.1016/j.ijpara.2006.09.009.

McGowan K, Kane A, Asarkof N; et al. (1983). "Entamoeba histolytica causes intestinal secretion: role of serotonin". Science 221 (4612): 762–4. PMID 6308760. doi:10.1126/science.6308760.

Park TJ, Comer C, Carol A, Lu Y, Hong HS, Rice FL (2003). "Somatosensory organization and behavior in naked mole-rats: II. Peripheral structures, innervation, and selective lack of neuropeptides associated with thermoregulation and pain". J Comp Neurol 465 (1): 104–20. PMID 12926019. doi:10.1002/cne.10824.

nih.gov

ncbi.nlm.nih.gov

Harrison S, Geppetti P (2001). "Substance p". The International Journal of Biochemistry & Cell Biology 33 (6): 555–76. PMID 11378438. doi:10.1016/S1357-2725(01)00031-0.

Panula P, Hadjiconstantinou M, Yang HY, Costa E (1983). "Immunohistochemical localization of bombesin/gastrin-releasing peptide and substance P in primary sensory neurons". Journal of Neuroscience 3 (10): 2021–9. PMID 6194276.

Maggi CA (1995). "The mammalian tachykinin receptors". Gen. Pharmacol. 26 (5): 911–44. PMID 7557266. doi:10.1016/0306-3623(94)00292-U.

Grady EF, Garland AM, Gamp PD, Lovett M, Payan DG, Bunnett NW (1995). "Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor". Molecular Biology of the Cell 6 (5): 509–24. PMC 301212. PMID 7545030.

Yip J, Chahl LA (2001). "Localization of NK1 and NK3 receptors in guinea-pig brain". Regulatory peptides 98 (1-2): 55–62. PMID 11179779. doi:10.1016/S0167-0115(00)00228-7.

Ebner K, Singewald N (2006). "The role of substance P in stress and anxiety responses". Amino Acids 31 (3): 251–72. PMID 16820980. doi:10.1007/s00726-006-0335-9.

Bonham AC (1995). "Neurotransmitters in the CNS control of breathing". Respiration physiology 101 (3): 219–30. PMID 8606995. doi:10.1016/0034-5687(95)00045-F.

Zubrzycka M, Janecka A (2000). "Substance P: transmitter of nociception (Minireview)". Endocrine regulations 34 (4): 195–201. PMID 11137976.

Donkin JJ, Turner RJ, Hassan I, Vink R (2007). "Substance P in traumatic brain injury". Progress in brain research 161: 97–109. PMID 17618972. doi:10.1016/S0079-6123(06)61007-8.

Hornby PJ (2001). "Central neurocircuitry associated with emesis". The American Journal of Medicine. 111. Suppl 8A (8): 106S–112S. PMID 11749934. doi:10.1016/S0002-9343(01)00849-X.

Brown SM, Lamberts DW, Reid TW, Nishida T, Murphy CJ (1997). "Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1". Archives of Ophthalmology 115 (7): 926–7. PMID 9230840.

Tsui H, Razavi R, Chan Y, Yantha J, Dosch HM (2007). "'Sensing' autoimmunity in type 1 diabetes". Trends in Molecular Medicine 13 (10): 405–13. PMID 17900987. doi:10.1016/j.molmed.2007.07.006.

Brown, M and Vale, W (1976). "Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels". Endocrinology 98 (3): 819–822. PMID 1261503. doi:10.1210/endo-98-3-819.

Bossaller C, Reither K, Hehlert-Friedrich C, Auch-Schwelk W, Graf K, Gräfe M, Fleck E (1992). "In vivo measurement of endothelium-dependent vasodilation with substance P in man". Herz 17 (5): 284–90. PMID 1282120.

Steinitz H (1979). "[Chronic recurrent intestinal amebiasis in Israel (author's transl)]". Leber, Magen, Darm (en German) 9 (4): 175–9. PMID 491812.

McGowan K, Kane A, Asarkof N; et al. (1983). "Entamoeba histolytica causes intestinal secretion: role of serotonin". Science 221 (4612): 762–4. PMID 6308760. doi:10.1126/science.6308760.

McGowan K, Guerina V, Wicks J, Donowitz M (1985). "Secretory hormones of Entamoeba histolytica". Ciba Found. Symp. 112: 139–54. PMID 2861068.

pubchem.ncbi.nlm.nih.gov

PubChem compound Substance P

Substancia P (Galician Wikipedia)

acs.org

pubs.acs.org

archive.org

bbc.co.uk

news.bbc.co.uk

bentham-direct.org

chemspider.com

doi.org

dx.doi.org

jneurosci.org

molbiolcell.org

newscientist.com

nih.gov

ncbi.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

web.archive.org

wiley.com

onlinelibrary.wiley.com